Abstract / Description of output
BACKGROUND: Smoking impacts DNA methylation, but data are lacking on smoking-related differential methylation by sex or dietary intake, recent smoking cessation (<1 year), persistence of differential methylation from in utero smoking exposure, and effects of environmental tobacco smoke (ETS).
METHODS: We meta-analysed data from up to 15,014 adults across 5 cohorts with DNA methylation measured in blood using Illumina's EPIC array for current smoking (2560 exposed), quit < 1 year (500 exposed), in utero (286 exposed), and ETS exposure (676 exposed). We also evaluated the interaction of current smoking with sex or diet (fibre, folate, and vitamin C).
FINDINGS: Using false discovery rate (FDR < 0.05), 65,857 CpGs were differentially methylated in relation to current smoking, 4025 with recent quitting, 594 with in utero exposure, and 6 with ETS. Most current smoking CpGs attenuated within a year of quitting. CpGs related to in utero exposure in adults were enriched for those previously observed in newborns. Differential methylation by current smoking at 4-71 CpGs may be modified by sex or dietary intake. Nearly half (35-50%) of differentially methylated CpGs on the 450 K array were associated with blood gene expression. Current smoking and in utero smoking CpGs implicated 3049 and 1067 druggable targets, including chemotherapy drugs.
INTERPRETATION: Many smoking-related methylation sites were identified with Illumina's EPIC array. Most signals revert to levels observed in never smokers within a year of cessation. Many in utero smoking CpGs persist into adulthood. Smoking-related druggable targets may provide insights into cancer treatment response and shared mechanisms across smoking-related diseases.
FUNDING: Intramural Research Program of the National Institutes of Health, Norwegian Ministry of Health and Care Services and the Ministry of Education and Research, Chief Scientist Office of the Scottish Government Health Directorates and the Scottish Funding Council, Medical Research Council UK and the Wellcome Trust.
Original language | English |
---|---|
Article number | 104956 |
Journal | EBioMedicine |
Volume | 100 |
Early online date | 9 Jan 2024 |
DOIs | |
Publication status | Published - Feb 2024 |
Keywords / Materials (for Non-textual outputs)
- Dietary intake
- Epigenomics
- Illumina EPIC array
- Secondhand smoke exposure
- Sex difference
- Smoking cessation
Access to Document
- START_AdultSmoking_DNAm_ebiomedicine v9_clean
Open Access. This article is licensed under a Creative Commons Attribution 4.0 International License (CC BY 4.0), which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http:// creat iveco mmons. org/ licen ses/ by/4. 0/.
Accepted author manuscript, 287 KBLicence: Creative Commons: Attribution (CC-BY)
Other files and links
Fingerprint
Dive into the research topics of 'Comprehensive evaluation of smoking exposures and their interactions on DNA methylation'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver
}
In: EBioMedicine, Vol. 100, 104956, 02.2024.
Research output: Contribution to journal › Article › peer-review
TY - JOUR
T1 - Comprehensive evaluation of smoking exposures and their interactions on DNA methylation
AU - Hoang, Thanh T
AU - Lee, Yunsung
AU - McCartney, Daniel L
AU - Kersten, Elin T.G
AU - Page, Christian M.
AU - Hulls, Paige M
AU - Lee, Mikyeong
AU - Walker, Rosie
AU - Breeze, Charles E.
AU - Bennett, Brian D
AU - Burkholder, Adam
AU - Ward, James
AU - Brantsæter, Anne Lise
AU - Caspersen, Ida H
AU - Motsinger-Reif, Alison
AU - Richards, Marie
AU - White, Julie D
AU - Zhao, Shanshan
AU - Richmond, Rebecca C
AU - Magnus, Maria C.
AU - The BIOS Consortium, null
AU - Koppelman, Gerard H
AU - Evans, Kathryn Louise
AU - Marioni, Riccardo E
AU - Håberg, Siri E.
AU - London, Stephanie J
N1 - Funding Information: Generation Scotland received core support from the Chief Scientist Office of the Scottish Government Health Directorates ( CZD/16/6 ) and the Scottish Funding Council ( HR03006 ). DNA methylation profiling of the GS samples was carried out by the Genetics Core Laboratory at the Clinical Research Facility, University of Edinburgh, Edinburgh, Scotland and was funded by the Medical Research Council UK and the Wellcome Trust (Wellcome Trust Strategic Award “STratifying Resilience and Depression Longitudinally” ([STRADL; Reference 104036/Z/14/Z ]). Funding Information: This study makes use of data generated by the Biobank-based Integrative Omics Study (BIOS) consortium. A full list of the investigators is available from http://www.bbmri.nl/en-gb/activities/rainbow-projects/bios . Funding for the project was provided by the Netherlands Organisation for Scientific Research ( NWO 184.021.007 , dated July 9, 2009) and made available as a Rainbow Project of the Biobanking and Biomolecular Research Infrastructure Netherlands (BBMRI-NL). ETGK received a grant from the Netherlands Lung Foundation . GHK received grants or contracts from ZonMw , Vertex , Netherlands Lung Foundation , GSK , Teva the Netherlands, and European Union . Funding Information: This work was supported in part by the Intramural Research Program of the National Institutes of Health , National Institute of Environmental Health Sciences (NIEHS; Z01-ES102385 , Z01-ES049030 , Z01-ES043012 ) and the National Cancer Institute ( Z01-CP010119 ). This work was also supported in part by American Recovery and Reinvestment Act (ARRA) funds through NIEHS contract number N01-ES-55546 . Funding Information: The Norwegian Mother, Father and Child Cohort Study is supported by the Norwegian Ministry of Health and Care Services and the Ministry of Education and Research . The work was partly funded by the Research Council of Norway through its Centre's of Excellence funding scheme (project No 262700 ). MCM received grants from the Research Council of Norway and European Research Council . Funding Information: Intramural Research Program of the National Institutes of Health, Norwegian Ministry of Health and Care Services and the Ministry of Education and Research, Chief Scientist Office of the Scottish Government Health Directorates and the Scottish Funding Council, Medical Research Council UK and the Wellcome Trust.The Norwegian Mother, Father and Child Cohort Study is supported by the Norwegian Ministry of Health and Care Services and the Ministry of Education and Research. The work was partly funded by the Research Council of Norway through its Centre's of Excellence funding scheme (project No 262700). MCM received grants from the Research Council of Norway and European Research Council. This work was supported in part by the Intramural Research Program of the National Institutes of Health, National Institute of Environmental Health Sciences (NIEHS; Z01-ES102385, Z01-ES049030, Z01-ES043012) and the National Cancer Institute (Z01-CP010119). This work was also supported in part by American Recovery and Reinvestment Act (ARRA) funds through NIEHS contract number N01-ES-55546. Generation Scotland received core support from the Chief Scientist Office of the Scottish Government Health Directorates (CZD/16/6) and the Scottish Funding Council (HR03006). DNA methylation profiling of the GS samples was carried out by the Genetics Core Laboratory at the Clinical Research Facility, University of Edinburgh, Edinburgh, Scotland and was funded by the Medical Research Council UK and the Wellcome Trust (Wellcome Trust Strategic Award “STratifying Resilience and Depression Longitudinally” ([STRADL; Reference 104036/Z/14/Z]). For UKHLS, the epigenetics methylation data were analysed by the University of Exeter Medical School (MRC grant K013807) and further facilitated by the University of Essex School of Biological Sciences. Understanding Society is an initiative funded by the Economic and Social Research Council (ES/N00812X/1) and various Government Departments, with scientific leadership by the Institute for Social and Economic Research, University of Essex, and survey delivery by NatCen Social Research and Kantar Public. RCR is supported by a de Pass Vice Chancellor's Fellowship at the University of Bristol. This study makes use of data generated by the Biobank-based Integrative Omics Study (BIOS) consortium. A full list of the investigators is available from http://www.bbmri.nl/en-gb/activities/rainbow-projects/bios. Funding for the project was provided by the Netherlands Organisation for Scientific Research (NWO 184.021.007, dated July 9, 2009) and made available as a Rainbow Project of the Biobanking and Biomolecular Research Infrastructure Netherlands (BBMRI-NL). ETGK received a grant from the Netherlands Lung Foundation. GHK received grants or contracts from ZonMw, Vertex, Netherlands Lung Foundation, GSK, Teva the Netherlands, and European Union. We are grateful to Stacey Mantooth and the NIEHS library for their assistance with the literature search. We appreciate all the study participants for their contribution to this research. Funding Information: For UKHLS, the epigenetics methylation data were analysed by the University of Exeter Medical School (MRC grant K013807 ) and further facilitated by the University of Essex School of Biological Sciences. Understanding Society is an initiative funded by the Economic and Social Research Council ( ES/N00812X/1 ) and various Government Departments, with scientific leadership by the Institute for Social and Economic Research, University of Essex , and survey delivery by NatCen Social Research and Kantar Public . RCR is supported by a de Pass Vice Chancellor's Fellowship at the University of Bristol . Publisher Copyright: © 2024 The Authors
PY - 2024/2
Y1 - 2024/2
N2 - BACKGROUND: Smoking impacts DNA methylation, but data are lacking on smoking-related differential methylation by sex or dietary intake, recent smoking cessation (<1 year), persistence of differential methylation from in utero smoking exposure, and effects of environmental tobacco smoke (ETS).METHODS: We meta-analysed data from up to 15,014 adults across 5 cohorts with DNA methylation measured in blood using Illumina's EPIC array for current smoking (2560 exposed), quit < 1 year (500 exposed), in utero (286 exposed), and ETS exposure (676 exposed). We also evaluated the interaction of current smoking with sex or diet (fibre, folate, and vitamin C).FINDINGS: Using false discovery rate (FDR < 0.05), 65,857 CpGs were differentially methylated in relation to current smoking, 4025 with recent quitting, 594 with in utero exposure, and 6 with ETS. Most current smoking CpGs attenuated within a year of quitting. CpGs related to in utero exposure in adults were enriched for those previously observed in newborns. Differential methylation by current smoking at 4-71 CpGs may be modified by sex or dietary intake. Nearly half (35-50%) of differentially methylated CpGs on the 450 K array were associated with blood gene expression. Current smoking and in utero smoking CpGs implicated 3049 and 1067 druggable targets, including chemotherapy drugs.INTERPRETATION: Many smoking-related methylation sites were identified with Illumina's EPIC array. Most signals revert to levels observed in never smokers within a year of cessation. Many in utero smoking CpGs persist into adulthood. Smoking-related druggable targets may provide insights into cancer treatment response and shared mechanisms across smoking-related diseases.FUNDING: Intramural Research Program of the National Institutes of Health, Norwegian Ministry of Health and Care Services and the Ministry of Education and Research, Chief Scientist Office of the Scottish Government Health Directorates and the Scottish Funding Council, Medical Research Council UK and the Wellcome Trust.
AB - BACKGROUND: Smoking impacts DNA methylation, but data are lacking on smoking-related differential methylation by sex or dietary intake, recent smoking cessation (<1 year), persistence of differential methylation from in utero smoking exposure, and effects of environmental tobacco smoke (ETS).METHODS: We meta-analysed data from up to 15,014 adults across 5 cohorts with DNA methylation measured in blood using Illumina's EPIC array for current smoking (2560 exposed), quit < 1 year (500 exposed), in utero (286 exposed), and ETS exposure (676 exposed). We also evaluated the interaction of current smoking with sex or diet (fibre, folate, and vitamin C).FINDINGS: Using false discovery rate (FDR < 0.05), 65,857 CpGs were differentially methylated in relation to current smoking, 4025 with recent quitting, 594 with in utero exposure, and 6 with ETS. Most current smoking CpGs attenuated within a year of quitting. CpGs related to in utero exposure in adults were enriched for those previously observed in newborns. Differential methylation by current smoking at 4-71 CpGs may be modified by sex or dietary intake. Nearly half (35-50%) of differentially methylated CpGs on the 450 K array were associated with blood gene expression. Current smoking and in utero smoking CpGs implicated 3049 and 1067 druggable targets, including chemotherapy drugs.INTERPRETATION: Many smoking-related methylation sites were identified with Illumina's EPIC array. Most signals revert to levels observed in never smokers within a year of cessation. Many in utero smoking CpGs persist into adulthood. Smoking-related druggable targets may provide insights into cancer treatment response and shared mechanisms across smoking-related diseases.FUNDING: Intramural Research Program of the National Institutes of Health, Norwegian Ministry of Health and Care Services and the Ministry of Education and Research, Chief Scientist Office of the Scottish Government Health Directorates and the Scottish Funding Council, Medical Research Council UK and the Wellcome Trust.
KW - Dietary intake
KW - Epigenomics
KW - Illumina EPIC array
KW - Secondhand smoke exposure
KW - Sex difference
KW - Smoking cessation
U2 - 10.1016/j.ebiom.2023.104956
DO - 10.1016/j.ebiom.2023.104956
M3 - Article
C2 - 38199042
SN - 2352-3964
VL - 100
JO - EBioMedicine
JF - EBioMedicine
M1 - 104956
ER -